SUMMARY A Welsh multicentre trial of early (fifth day) compared with late (tenth day) mobilisation in 742 patients after uncomplicated myocardial infarction, reported previously, found that there were no significant differences in survival during the first year, but a partial follow up beyond the first year survival showed a significantly reduced survival during the second and third years among patients mobilised early. A full 10 year follow up of all patients admitted to the trial was therefore carried out. A small difference in survival was confirmed, which reached about 5% at four years; but the difference was not statistically significant. Further analysis suggested the possibility of real differences in survival in certain subgroups, but the present evidence was not sufficient to provide contraindication to mobilisation five days after uncomplicated myocardial infarction.
Since Levine and Lown advocated armchair treatment for patients with acute coronary thrombosis' there has been a progressive reduction in the average duration of bed rest. There have been several randomised trials of duration of bed rest and duration of stay in hospital (cited in2). In the previously reported Welsh multicentre trial of early mobilisation after uncomplicated acute myocardial infarction 742 patients were randomised to five days or to 10 days of bed rest. The early and late mobilisation groups were comparable, and no significant differences in mortality or in morbidity in the first year were found.2 Similar smaller trials have shown no disadvantage of early mobilisation either in mortality or in morbidity during shorter follow up periods, usually of six weeks to six months (cited in2). In our Welsh trial, however, follow up information was available for some patients beyond one year, because the intended one year follow up was inadvertently delayed. An unexpected finding from that incomplete late follow up was that the survival rates of the two groups diverged during the second and third years after trial entry, with those mobilised early having significantly higher mortality. The finding has given rise to some concern about the advisability of early mobilisation. 3 We report the full follow up data eight to 10 The numbers of patients admitted to the two groups differed slightly; 348 were mobilised on day 5 and 394 on day 10. This degree of inequality is not significant: the limits are 343 and 399 (at 2a=0 05). Much of the inequality was contributed by two consultants, who admitted 8 and 23 and 14 and 23 patients on days 5 and 10 respectively. The former inequality is significant (limits 9 and 22) while the latter is not (limits 12 and 25). Since the inequality for the trial as a whole was not significant and since there were 31 consultants it is quite possible that a "significant" inequality could have occurred by chance for one. Nevertheless, in case there should have been any selection bias all survival calculations were reworked excluding (a) the 31 patients admitted by the one consultant and (b) the further 37 patients admitted by the other consultant. Figure 1 shows the survival curves of patients mobilised on day 5 and those mobilised on day 10 after uncomplicated acute myocardial infarction. One year after admission to the Welsh multicentre trial 88% of those mobilised early and 89% of those mobilised late survived: the first year survivals were not statistically different.2 During the second to sixth years the survival of those mobilised early appeared to be somewhat lower than for those mobilised late, with a maximum apparent difference of 5% at four years. The difference was not, however, statistically significant (Mantel Haenszel logrank 0-4 y X2=2 3 and p-0-13). The survival rates were more similar over the seVenth to ninth years but separated again in the final year. Ten years after admission to the trial 51% of those mobilised early and 55% of those mobilised late survived: the overall 0-10 years difference was not statistically significant. Of all 742 patients, 16 were lost to follow up before eight years and 38 and 172 were "right censored" during the ninth and tenth years respectively. The overall survival rate after 10 years was 53%. The mortality rate in the first year was 11% and the annual mortality rate after the first year 4%.
SURVIVAL IN SUBGROUPS
The survivals of patients mobilised on day 5 and on day 10 were compared in various subgroups (by age, sex, hospital, previous medical history, and clinical findings on admission) to look for an explanation for the apparent separation of the curves, particularly in the second to sixth years. The Table summarises the results at four years, the centre of the separation, and at 10 years. Several subgroups showed a higher mortality from about one year after infarction in the early mobilisation group: (a) patients admitted to hospital F, (n= 110, Mantel Haenszel 0-4 yr, p<005), (b) patients with previous history of hypertension (n= 83, Fig. 2a, p<0 05) , (c) patients with arrhythmia on admission (n= 137, Fig. 2b, p<0 .01), and (d) patients with bradycardia on admission (heart rate <60 beats/min, n=58, Fig. 2c, p<0 02) . Most of these differences were at their greatest about four years after trial entry. For patients with a previous history of angina and for those with hypotension on admission the apparent differences were not significant. The differences in the opposite sense at four years (apparently lower mortality among those mobilised early) among patients admitted to hospital C and among the relatively few patients who had histories of previous myocardial infarction or who had tachycardia on admission were all not significant. 10 year survival of 41% (p<00001), and 83 had histories of hypertension with a 10 year survival of 41% (p<001). Of the potential "risk features" on admission to hospital, tachycardia (heart rate -120 beats/ min) conferred a lower than average survival (21% survival at 10 years, p<0001) and so did severe dyspnoea (24% survival at 10 years, p<001).
CAUSES OF DEATH
The causes of death (Ic, Ib, or Ia on the death certificate) were described as (a) heart disease (ICD 410-414) 71%, (b) other circulatory diseases (ICD 390-405 and 415-459) 18% (mostly hypertension, cerebrovascular disease, and arteriosclerosis), and (c) other causes 11% (mostly cancer). There were slightly more deaths from heart disease and fewer from other circulatory diseases among patients mobilised early: 74% and 16% respectively for day 5 compared with 68% and 19% for day 10, but these differences were not statistically significant. There were fewer deaths from heart disease and more from other causes (group c) in old patients; 59% and 20% respectively of those aged over 65 (p<005). There were more deaths due to heart disease during the first year (84%) and more deaths from other circulatory disease (22%) and other causes (14%) during the second to sixth years (p<0*02). 
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infarction has shown that the lower survival after early mobilisation on the fifth day compared with late mobilisation on the tenth day that appeared during X the partial 2-3 year follow up was not significant in -'~~the trial as a whole. A small non-significant difference in survival between the early and late mobilisation groups was confirmed, reaching a maximum of about 5% at four years. Subgroups of patients were identified with significantly lower survival after early mobilisation: patients admitted to hospital F, patients ' with a history of hypertension, and patients with bradycardia or arrhythmia on admission to hospital. Only the last two of these groups overlapped significantly; 28/137 with arrhythmia also had bradycardia.
----------Overall mortality after the fifth day for patients with uncomplicated myocardial infarction was 11% in --____ the first year and approximately 4% a year thereafter. This is marginally less than previously reported mortality rates after acute myocardial infarction, although close comparisons are not possible because of differences between series.'2 It also compares quite favourably with the expected mortality of about 2% in the normal population of the-same sex and age dis- Long term survival ofpatients mobilised early after acute myocardial infarction sions to the trial. The non-significant excess of patients mobilised late has been shown to be attributable to entries on behalf of two of the 31 participating consultants. Exclusion of data from these sources resulted in a slight widening of the differences in survival but not to the point of significance.
The significantly lower survival after early mobilisation in four of the 23 subgroups compared in the Table, the levels of significance of the survival differences, and the heightening of the differences after exclusion of data from the two consultants whose distribution of admitted patients showed possible bias taken together suggest that the differences may be more than a random consequence of multiple comparisons. It is possible that there is a small but "real" disadvantage of early mobilisation in terms of late survival, which could achieve statistical significance only in future larger trials. The overall difference, however, was maximal at four years, whereas a "real" difference might have been expected to be maximal during the first year when mortality is highest. Furthermore, the features distinguishing three of those subgroups apparently disadvantaged by early mobilisation do not obviously identify any clinical characteristics that might reasonably be considered as potential hazards: of the four subgroups, only hypertension was associated with reduced survival in the trial as a whole. The overall difference was at no time large. We believe that the evidence is not sufficient to contraindicate mobilisation as early as the fifth day after uncomplicated myocardial infarction.
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